FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental application for Novo Nordisk's Novolin 70/30 (human insulin), updating the product's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NOVOLIN 70/30 (HUMAN INSULIN)

Snippet

SUPPL AP for NOVOLIN 70/30 (HUMAN INSULIN)